Published 1/12/18 in the Daily Record The GammaPod uses stereotactic radiation to treat breast cancer. It was invented at the University of Maryland School of Medicine. (Submitted photo) A Maryland company can now begin marketing its device, which could change …
Published 12/15/17 on UMB News Maryland has made significant progress in combating human trafficking, but there is much more work to be done, according to experts and panelists who attended a recent conference hosted by the University of Maryland School of …
Published 1/8/18 on Technical.ly/Baltimore After years of development from the University of Maryland School of Medicine and a Columbia-based company, the GammaPod will be used for treatment in Baltimore in 2018. After nearly a decade in development, a device …
Published 12/22/17 on Technical.ly Baltimore A string of exits was one of the defining stories for Baltimore’s tech community this year. Startups such as Parking Panda, RedOwl and Harpoon Medical are among those with new owners. While 2016 was marked …
Published 12/28/17 in the Baltimore Business Journal A Baltimore startup developing artificial organ technology has raised about $3 million in equity funding, according to U.S. Securities and Exchange Commission documents. Medical device firm Breethe Inc. reported the round this month, …
Published 12/20/17 in The Daily Record After years of groundwork, Maryland universities saw more tangible results this year from their efforts to support new startups formed from university technology. State and university officials hope this year’s results show a state …
Published 12/18/17 in The Baltimore Sun Baltimore medical device company Harpoon Medical’s acquisition earlier this month was a windfall for The Abell Foundation, one of its early investors. The nonprofit said it earned $5.2 million on the deal, a 10-times …
Published 12/18/17 on Technical.ly Baltimore Abell Foundation says money from the the acquisition will go toward its grant-making budget for community efforts. It illustrates why the foundation invests in medtech startups. A startup’s exit can produce many ripple effects that …
Published on 12/14/17 on citybizlist Recently, I had lunch with David Wise at City Café to discuss the subject of investment capital for early stage companies. Until the end of July, David had been the venture advisor to the Abell Foundation. He is …
Published 12/15/17 on UMD Right Now COLLEGE PARK, Md.– A new research initiative by the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh could help uncover how T-cells—the “killer cells” that defend the …